Physician profile
Michael E Summerfield
NPI 1588690358
$35,130.00
in general payments reported to CMS, 2019-2025
34 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $523 · 2021: $3,313 · 2022: $4,437 · 2023: $4,360 · 2024: $570 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,275 · Food and Beverage: $2,359 · Travel and Lodging: $39.30 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,275.00 |
| Food and Beverage | $2,358.53 |
| Travel and Lodging | $39.30 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22,868.06 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $6,476.42 | 2022-2023 | Envista Mx60 Iol |
| Alcon Vision LLC | $1,706.30 | 2019-2025 | Clareon, Clareon Panoptix Pro, Unity |
| New World Medical,INC. | $784.91 | 2021-2023 | |
| Abbvie INC. | $561.38 | 2023-2025 | Durysta, Xen Glaucoma Treatment System, Ozurdex |
| Johnson & Johnson Surgical Vision, INC. | $503.75 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Rxsight INC | $248.53 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Kala Pharmaceuticals, INC. | $245.89 | 2019-2022 | |
| Glaukos Corporation | $212.82 | 2019-2023 | Iaccess Precision Blade, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $200.44 | 2019-2024 | |
| Carl Zeiss Meditec USA, INC. | $179.74 | 2022 | |
| Eyepoint US, INC. | $145.52 | 2021 | |
| Horizon Therapeutics Plc | $139.85 | 2021-2023 | Tepezza |
| Sight Sciences, INC. | $95.65 | 2019-2022 | |
| Oyster Point Pharma, INC. | $89.87 | 2022-2023 | Tyrvaya |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $78.40 | 2023-2024 | Omidria, Rayone Spheric, Rayone Aspheric |
| Allergan, INC. | $72.72 | 2019-2021 | |
| Thea Pharma INC. | $49.20 | 2023 | Iyuzeh |
| Amgen INC. | $49.10 | 2024 | Tepezza |
| Mallinckrodt Enterprises LLC | $45.94 | 2019 | |
| Staar Surgical Company | $45.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.18 | 2025 | Eylea Hd |
| Ocular Therapeutix, INC. | $32.83 | 2021 | |
| Biotissue Holdings INC. | $30.77 | 2024-2025 | |
| Aerie Pharmaceuticals, INC. | $29.44 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $27.39 | 2024 | Xdemvy |
| Dompe US, INC. | $26.69 | 2022 | |
| Eyevance Pharmaceuticals LLC | $24.79 | 2023 | Flarex |
| Harrow Eye, LLC | $20.49 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Genentech USA, INC. | $12.34 | 2022 | |
| Omeros Corporation | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Summerfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.